Associated Papers
Characterization of the genomic alterations in poorly differentiated thyroid cancer.
Lee Y et al.
Scientific Reports, 2023
37932340 (PubMed )
Supplement: 41598_2023_46466_MOESM2_ESM.xlsx › P01
Whole genome sequencing of Malaysian colorectal cancer patients reveals specific druggable somatic mutations.
Mohd Yunos RI et al.
Frontiers in Molecular Biosciences, 2022
Genomic and transcriptomic profiling of carcinogenesis in patients with familial adenomatous polyposis.
Li J et al.
Gut, 2020
31744909 (PubMed )
Supplement: gutjnl-2019-319438supp006.xlsx › _FAP__All_somatic_mutation
Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.
Dufva O et al.
Nature Communications, 2018
29674644 (PubMed )
Supplement: 41467_2018_3987_MOESM6_ESM.xlsx › NKTCL_L11
Genomic profiling reveals mutational landscape in parathyroid carcinomas.
Pandya C et al.
Jci Insight, 2017
The genomic complexity of primary human prostate cancer.
Berger MF et al.
Nature, 2011
21307934 (PubMed )
Supplement: NIHMS257464-supplement-2.xlsx › TABLE_S3
Select a paper to view details